These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27030398)

  • 21. Reduction of enhanced rabbit intraocular pressure by instillation of pyroglutamic acid eye drops.
    Ito Y; Nagai N; Okamoto N; Shimomura Y; Nakanishi K; Tanaka R
    Biol Pharm Bull; 2013; 36(6):1017-23. PubMed ID: 23727922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin.
    Pop E; Loftsson T; Bodor N
    Pharm Res; 1991 Aug; 8(8):1044-9. PubMed ID: 1924158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.
    Gross S; Abraham U; Prior JL; Herzog ED; Piwnica-Worms D
    Mol Imaging; 2007; 6(2):121-30. PubMed ID: 17445506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compatibility of hydroxypropyl-beta-cyclodextrin with algal toxicity bioassays.
    Fai PB; Grant A; Reid BJ
    Environ Pollut; 2009 Jan; 157(1):135-40. PubMed ID: 18775592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced desorption of phenanthrene from soils using hydroxypropyl-beta-cyclodextrin: experimental results and model predictions.
    Ko SO; Yoo HC
    J Environ Sci Health B; 2003 Nov; 38(6):829-41. PubMed ID: 14649712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing a potential in vivo drug-excipient interaction: temporal effects of a modified β-cyclodextrin on the intravenous pharmacokinetics of a model high-affinity drug ligand.
    Mannila A; Morizzi J; Nguyen TT; Charman SA; McIntosh MP; Shackleford DM
    J Pharm Sci; 2012 Sep; 101(9):3381-9. PubMed ID: 22549698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Sensitivity In Vivo Imaging of Cancer Metastasis Using a Near-Infrared Luciferin Analogue seMpai.
    Nakayama J; Saito R; Hayashi Y; Kitada N; Tamaki S; Han Y; Semba K; Maki SA
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the delivery efficiency of drug-loaded microbubbles in cancer cells with ultrasound and bioluminescence imaging.
    Liao AH; Li YK; Lee WJ; Wu MF; Liu HL; Kuo ML
    Ultrasound Med Biol; 2012 Nov; 38(11):1938-48. PubMed ID: 22929655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol.
    Doenicke A; Roizen MF; Nebauer AE; Kugler A; Hoernecke R; Beger-Hintzen H
    Anesth Analg; 1994 Nov; 79(5):933-9. PubMed ID: 7978412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative bioluminescence imaging of transgene expression in vivo.
    Rettig GR; McAnuff M; Liu D; Kim JS; Rice KG
    Anal Biochem; 2006 Aug; 355(1):90-4. PubMed ID: 16737677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.
    Loftsson T; Bodor N
    Acta Pharm Nord; 1989; 1(4):185-94. PubMed ID: 2590460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A synthetic luciferin improves in vivo bioluminescence imaging of gene expression in cardiovascular brain regions.
    Simonyan H; Hurr C; Young CN
    Physiol Genomics; 2016 Oct; 48(10):762-770. PubMed ID: 27614203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Label-Free Cell Phenotypic Identification of D-Luciferin as an Agonist for GPR35.
    Hu H; Deng H; Fang Y
    Methods Mol Biol; 2016; 1461():3-17. PubMed ID: 27424891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissolution, cyclodextrin-enhanced solubilization, and mass removal of an ideal multicomponent organic liquid.
    Carroll KC; Brusseau ML
    J Contam Hydrol; 2009 Apr; 106(1-2):62-72. PubMed ID: 19233508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen.
    Godwin DA; Wiley CJ; Felton LA
    Eur J Pharm Biopharm; 2006 Jan; 62(1):85-93. PubMed ID: 16137872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The solubilization effect of 2-hydroxypropyl-beta-cyclodextrin on paeonolum].
    Jian LY; Yang YH; Xu YH; He ZG
    Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(15):1154-6. PubMed ID: 16201687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of hydroxypropyl-beta-cyclodextrin on transdermal penetration and photostability of avobenzone.
    Yang J; Wiley CJ; Godwin DA; Felton LA
    Eur J Pharm Biopharm; 2008 Jun; 69(2):605-12. PubMed ID: 18226883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-luciferin analogues: a multicolor toolbox for bioluminescence imaging.
    Sun YQ; Liu J; Wang P; Zhang J; Guo W
    Angew Chem Int Ed Engl; 2012 Aug; 51(34):8428-30. PubMed ID: 22807027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
    Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.